News & Updates
Showing Hepatology articles
Showing
Show Multimedia Only

Double trouble: Alcohol-related liver diseases take a turn for the worse during COVID-19
15 Nov 2021
byElvira Manzano
Higher intake of alcohol and reduced care during the COVID-19 pandemic have triggered a spike in alcohol-related liver diseases, leading to some serious consequences, according to new research.
15 Nov 2021

A3 adenosine receptor agonist safe, effective for treating NAFLD
10 Nov 2021
Namodenoson, an A3 adenosine receptor (A3AR) agonist, shows clinical activity against nonalcoholic fatty liver disease (NAFLD) with or without nonalcoholic steatohepatitis (NASH), according to data from a phase II study.
10 Nov 2021
